APA (7th ed.) Citation

L, P., J, Z., NS, P., U, G., P, P., M, S., . . . M, S. (2026). Safety of secondary CRS/HIPEC in peritoneal surface malignancies: Insights from a national cohort study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 52(3), 111408. https://doi.org/10.1016/j.ejso.2026.111408

Chicago Style (17th ed.) Citation

L, Pollmann, Zieren J, Pollmann NS, Giger-Pabst U, Piso P, Ströhlein M, Cerasani N, Kockelmann F, and Schmeding M. "Safety of Secondary CRS/HIPEC in Peritoneal Surface Malignancies: Insights from a National Cohort Study." European Journal of Surgical Oncology : The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 52, no. 3 (2026): 111408. https://doi.org/10.1016/j.ejso.2026.111408.

MLA (9th ed.) Citation

L, Pollmann, et al. "Safety of Secondary CRS/HIPEC in Peritoneal Surface Malignancies: Insights from a National Cohort Study." European Journal of Surgical Oncology : The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, vol. 52, no. 3, 2026, p. 111408, https://doi.org/10.1016/j.ejso.2026.111408.